ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 250 entries already.
The development of a sustainable bio-based economy will lead to disruptive economic changes. Venture capitalists focused on targets to drive digitisation in the past are now moving their attention to the bioeconomy
US Life Science leaders pledge to economically disengage from Russia.
Since the beginning of March, Dr Neil Torbett has been the new Chief Executive Officer of Cambridge-based PhoreMost Ltd.
Barcelona-based Integra Therapeutics appoints George Church to its Scientific Advisory Board.
InDex Pharmaceuticals needs a new COO. After ten years as Chief Operating Officer, Pernilla Sandwall will leave the Stockolm-based company at the end of April.
Laurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company.
Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.
Immunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.
Paris-based Onxeo S.A. has started the new year with an interim CEO. Julien Miara has taken over the position.
Eisbach Bio GmbH is a spin-off of the Ludwig Maximilian University in Munich. The company is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried.